cbdMD, Inc.
YCBD
$0.86
-$0.05-5.50%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -4.87% | -20.21% | -15.45% | -29.86% | -11.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.87% | -20.21% | -15.45% | -29.86% | -11.66% |
| Cost of Revenue | -5.78% | -2.74% | -22.14% | -19.27% | -27.79% |
| Gross Profit | -4.41% | -30.86% | -11.49% | -35.73% | -0.29% |
| SG&A Expenses | -24.64% | -31.26% | -32.10% | -25.09% | -24.91% |
| Depreciation & Amortization | 5.04% | -56.92% | -23.38% | -23.47% | -24.85% |
| Other Operating Expenses | -40.41% | -127.81% | -48.18% | -1.94% | -56.67% |
| Total Operating Expenses | -19.27% | -43.30% | -30.05% | -22.42% | -30.34% |
| Operating Income | 91.90% | 89.02% | 79.05% | -10.74% | 66.28% |
| Income Before Tax | 101.52% | 99.04% | 125.97% | -125.21% | 74.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 101.52% | 99.04% | 125.97% | -125.21% | 74.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 101.52% | 99.04% | 125.97% | -125.21% | 74.81% |
| EBIT | 91.90% | 89.02% | 79.05% | -10.74% | 66.28% |
| EBITDA | 127.07% | 98.70% | 92.99% | -12.21% | 71.90% |
| EPS Basic | 67.90% | 98.95% | 87.07% | 22.01% | 81.75% |
| Normalized Basic EPS | 95.42% | 98.32% | 85.59% | 1.04% | 84.58% |
| EPS Diluted | 67.90% | 98.94% | 87.07% | 22.15% | 81.77% |
| Normalized Diluted EPS | 95.42% | 98.32% | 85.59% | 1.04% | 84.58% |
| Average Basic Shares Outstanding | 53.74% | 552.15% | 50.99% | 120.06% | 120.75% |
| Average Diluted Shares Outstanding | 53.74% | 552.15% | 50.99% | 120.06% | 120.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |